Filing Flows › Comparisons › RCEL vs SGHT
Avita Medical vs Sight Sciences: RCEL and SGHT compared
Avita Medical is the larger company: $26.1M of revenue in its latest quarter (Q3 2026) against $24.9M for Sight Sciences (Q3 2026). Avita Medical is growing faster (+53% against +25% a year earlier). Avita Medical is more profitable, with an operating margin of -10.1% against -24.6%.
Where the money goes: RCEL and SGHT
Avita Medical (RCEL) · Q3 2026
Avita Medical, Q3 2026: revenue $26.1M (+53% year over year), operating margin -10.1%, net loss $6.2M, operating cash flow −$710K. The chart follows the revenue to costs, profit and cash.
Sight Sciences (SGHT) · Q3 2026
Sight Sciences, Q3 2026: revenue $24.9M (+25% year over year), operating margin -24.6%, net loss $6.8M, operating cash flow −$2.4M. The chart follows the revenue to costs, profit and cash.
| Avita Medical (RCEL) | Sight Sciences (SGHT) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $26.1M | $24.9M |
| Revenue growth, Y/Y | +53% | +25% |
| Operating margin | -10.1% | -24.6% |
| Net earnings | −$6.2M | −$6.8M |
| Net margin | -23.8% | -27.3% |
| Operating cash flow | −$710K | −$2.4M |
Where the revenue comes from
Sight Sciences
- Surgical Glaucoma: $21.0M (84%)
- Dry Eye: $3.9M (16%)
Questions
Which is bigger, Avita Medical or Sight Sciences?
Avita Medical is the larger company: $26.1M of revenue in its latest quarter (Q3 2026) against $24.9M for Sight Sciences (Q3 2026).
Is Avita Medical or Sight Sciences growing faster?
Avita Medical is growing faster (+53% against +25% a year earlier).
Which is more profitable, Avita Medical or Sight Sciences?
Avita Medical is more profitable, with an operating margin of -10.1% against -24.6%.
More: Avita Medical earnings · how Avita Medical makes money · Sight Sciences earnings · how Sight Sciences makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.